Company page

Geovax Labs, Inc.

Geovax Labs, Inc. (ticker: GOVX) is a public company based in the United States, focusing on the development of innovative vaccines and immunotherapies. With a market capitalization of approximately $3.81 million, Geovax is engaged in advancing its product pipeline to address various infectious diseases and cancers. The company aims to leverage its proprietary technologies to create effective solutions for global health challenges.